Friday, February 5, 2021

NPR Notícias de negócios: Johnson & Johnson Applies For Emergency Use Authorization For COVID-19 Vaccine

Johnson & Johnson Applies For Emergency Use Authorization For COVID-19 Vaccine
The company's vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.

leia mais em NPR

No comments:

Post a Comment